TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead. July 2, 2004
TCL Archive Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds April 13, 2012